82 Followers on Owler

Bit Bio

Read more
Mark Kotter's photo - Founder & CEO of Bit Bio

Founder & CEO

Mark Kotter

CEO Approval Rating

90/100

Founded:

2016

Status:

PrivateIndependent Company

Est. Annual Revenue
$14.3M
Agree?
Est. Employees
120
Agree?

BIT BIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Bit Bio's company profile
Mark Kotter's photo - Founder & CEO of Bit Bio

Mark Kotter

Founder & CEO

90/100
120
$42M
$14.3M
View Profile
1
Bit Bio's Competitor - Axol logo
Liam Taylor's photo - CEO of Axol

Liam Taylor

CEO

84/100
24
$4.6M
$3M
View Profile
2
Bit Bio's Competitor - DefiniGEN logo
Marcus Yeo's photo - Founder & CEO of DefiniGEN

Marcus Yeo

Founder & CEO

85/100
20
$10.4M
$3M
View Profile
3
Bit Bio's Competitor - REPROCELL logo
Chikafumi Yokoyama's photo - CEO of REPROCELL

Chikafumi Yokoyama

CEO

90/100
60
$350K
$5M
View Profile
4
Bit Bio's Competitor - Cell Applications logo
CEO Avatar

James Yu

Co-Founder & CEO

70/100
30
$150K
$4.9M
View Profile
5
Bit Bio's Competitor - Axiogenesis logo
Heribert Bohlen's photo - Co-Founder & CEO of Axiogenesis

Heribert Bohlen

Co-Founder & CEO

72/100
248
- -
$10M
View Profile
6
Bit Bio's Competitor - Forendo Pharma logo
Risto Lammintausta's photo - Co-Founder & CEO of Forendo Pharma

Risto Lammintausta

Co-Founder & CEO

89/100
21
$33.8M
$2.4M
View Profile
7
Bit Bio's Competitor - Cellular Dynamics International, Inc. logo
Kazuyoshi Hirao's photo - Chairman & CEO of Cellular Dynamics International, Inc.

Kazuyoshi Hirao

Chairman & CEO

71/100
495
$191.8M
$20.8M
View Profile
8
Bit Bio's Competitor - AVM Biotechnology logo
Manon Cox's photo - Interim-CEO of AVM Biotechnology

Manon Cox

Interim-CEO

90/100
20
$12.1M
$7.5M
View Profile
9
Bit Bio's Competitor - STEMCELL logo
Allen Eaves's photo - President & CEO of STEMCELL

Allen Eaves

President & CEO

98/100
1,500
$45M
$200M
View Profile
10
Bit Bio's Competitor - Lineage logo
Brian M. Culley's photo - CEO of Lineage

Brian M. Culley

CEO

87/100
79
$66.7M
$1.8M
View Profile
11
Bit Bio's Competitor - Pluriomics logo
Stefan Braam's photo - Co-Founder & CEO of Pluriomics

Stefan Braam

Co-Founder & CEO

72/100
39
$11.3M
$2M
View Profile
12
Bit Bio's Competitor - Arecor logo
Sarah Howell's photo - CEO of Arecor

Sarah Howell

CEO

89/100
24
$13.2M
$8M
View Profile

Missing a competitor? Contribute!

Axol is the top competitor of Bit Bio. Axol was founded in 2012, and its headquarters is in Cambridgeshire, England. Like Bit Bio, Axol also operates in the Biotechnology field. Axol has 96 fewer employees than Bit Bio.

DefiniGEN is seen as one of Bit Bio's top competitors. DefiniGEN was founded in Cambridge, England} in 2013. Like Bit Bio, DefiniGEN also works within the Biotechnology field. Compared to Bit Bio, DefiniGEN generates $11.3M less revenue.

REPROCELL is Bit Bio's #3 rival. REPROCELL's headquarters is in Beltsville, Maryland, and was founded in 2003. Like Bit Bio, REPROCELL also operates in the Biotechnology sector. REPROCELL generates 34% of Bit Bio's revenue.

Bit Bio Acquisitions

No recent acquisitions found related to Bit Bio

Bit Bio Funding History

Since Bit Bio was founded in 2016, it has participated in 2 rounds of funding. In total Bit Bio has raised $42.0M. Bit Bio's last funding round was on Jun 2020 for a total of $41.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Jun 2020
$41.5M
Seed
Nov 2017
$460.6K
-

Since Bit Bio was founded in 2016, it has participated in 2 rounds of funding. In total Bit Bio has raised $42.0M. Bit Bio's last funding round was on Jun 2020 for a total of $41.5M

Bit Bio Investments

No recent investments found related to Bit Bio

Bit Bio News

June 16, 2020Unquote

Foresite et al. in $41.5m series-A for Bit Bio | Unquote

Foresite is currently investing from its fourth-generation fund, which closed on $668m in 2018... See more »
June 15, 2020PharmaLive

Bit Bio Rakes in $41.5 Million in Series A

U.K.-based Bit Bio, a spinout of Cambridge University and previously known as Elpis Biotechnology, se... See more »
June 15, 2020Cambridge Independent

'Beautiful science' in 'operating system of life' underpins $41.5m investment in Bit Bio

'Our moonshot goal is to develop a platform capable of producing every human cell type,' says CEO/fou... See more »
June 15, 2020FirstWord Pharma

Bit Bio Secures $41.5 Million of Funding From Top Life Sciences Investors

Bit Bio, a Cambridge-based synthetic biology company combining data science and biology to code cells... See more »
June 14, 2020TechCrunch

Bit Bio's 'enter button for the keyboard to the software of life' nabs the company $41.5 million

Bit Bio, the new startup that pitches itself as the "enter button for the keyboard to the software of... See more »
June 9, 2020Business Weekly

Iconic US investors back Cambridge-based Bit Bio's $41.5m raise

Cambridge UK synthetic biology startup Bit Bio - formerly Elpis Biomed - has raised $41.5 million gro... See more »
February 25, 2020BioSpace

Bit Bio Secures Distribution Agreement with Abcam to Democratize Access to Human Cells for Global Life Science Research

Bit Bio announces agreement with Abcam, a global innovator in life science reagents and tools, to mak... See more »

Bit Bio Blogs

June 3, 2021bit bio Blog

The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs

Dr Daniel Ortmann, Head of DiscoveryBits of biobit.bioThe post The developmental capacity of nuclei t... See more »
June 3, 2021bit bio Blog

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Dr Anne-Claire Guénantin, Senior ScientistBits of biobit.bioThe post Induction of pluripotent ... See more »
June 3, 2021bit bio Blog

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

Dr Will Bernard, Senior ScientistBits of biobit.bioThe post In vivo reprogramming of murine cardiac f... See more »
June 3, 2021bit bio Blog

Direct conversion of fibroblasts to functional neurons by defined factors

Dr Tony Oosterveen, Senior ScientistBits of biobit.bioThe post Direct conversion of fibroblasts to fu... See more »
June 3, 2021bit bio Blog

Genetic content of adult somatic cells tested by nuclear transplantation from cultured cells

Dr Kaiser Karim, Senior ScientistBits of biobit.bioThe post Genetic content of adult somatic cells te... See more »
June 3, 2021bit bio Blog

Stepwise reprogramming of B cells into macrophages

Dr Thomas Moreau, Head of ResearchBits of biobit.bioThe post Stepwise reprogramming of B cells into m... See more »
June 3, 2021bit bio Blog

Haematopoietic stem and progenitor cells from human pluripotent stem cells

Dr Thomas Moreau, Head of ResearchBits of biobit.bioThe post Haematopoietic stem and progenitor cells... See more »

Bit Bio Press Releases

Social Media

Bit Bio Headquarters

The Dorothy Hodgkin Building Babraham Research Campus

Cambridge, EnglandCB22 3FH

44-1223-787297

Driving Directions »

Trending Companies

Bit Bio Summary

ABOUT

Overview

Bit Bio is a cell coding company that develops and commercializes human cell and tissue models for research and drug discovery applications. Bit Bio was founded in 2016. Bit Bio's headquarters is located in Cambridge, England, GB CB22 3FH. It has rais...

CEO

Bit Bio's Founder & CEO, Mark Kotter, currently has an approval rating of 90%. Bit Bio's primary competitors are Axol, DefiniGEN & REPROCELL.

Website

bit.bio

Frequently Asked Questions about Bit Bio

  1. When was Bit Bio founded?

    Bit Bio was founded in 2016
  2. Who is Bit Bio's CEO?

    Bit Bio's CEO is Mark Kotter
  3. How much revenue does Bit Bio generate?

    Bit Bio generates $14.3M in revenue
  4. How much funding does Bit Bio have?

    Bit Bio has historically raised $42M in funding
  1. Where is Bit Bio's headquarters?

    Bit Bio's headquarters is in Cambridge England, GB
  2. How many employees does Bit Bio have?

    Bit Bio has 120 employees
  3. What sector does Bit Bio operate in?

    Bit Bio is in Biotechnology
  4. Who are Bit Bio's competitors?

    Bit Bio's top competitors are Axol, DefiniGEN, REPROCELL